Publication Name	World Journal of Diabetes
Manuscript ID	62587
Country	Croatia

Received	2021-01-13 21:55
Peer-Review Started	2021-01-13 21:57
To Make the First Decision
Return for Revision	2021-04-20 22:50
Revised	2021-04-23 21:48
Second Decision	2021-05-19 06:49
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-05-19 12:04
Articles in Press	2021-05-19 12:04
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-05-27 18:49
Typeset the Manuscript	2021-06-03 06:14
Publish the Manuscript Online	2021-06-04 13:47

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Minireviews
Article Title	Effect of COVID-19 on management of diabetes type 1: Pushing the boundaries of telemedical healthcare
Manuscript Source	Invited Manuscript
All Author List	Ines Bilic Curcic, Maja Cigrovski Berkovic, Tomislav Kizivat, Silvija Canecki Varzic, Robert Smolic and Martina Smolic
Funding Agency and Grant Number	Funding Agency Grant Number Ines Bilić-Ćurčić ZUP2018-90
Corresponding Author	Martina Smolic, MD, PhD, Associate Professor, Department for Pharmacology, Faculty of Medicine Osijek, J Huttlera 4, Osijek 31000, Croatia. martina.smolic@mefos.hr
Key Words	Diabetes management; Telemedicine; COVID-19; Diabetes type 1
Core Tip	Mortality and morbidity rates are increased during coronavirus disease 2019 pandemics partially due to disruption in health care delivery. The implementation of telemedicine imposes itself as a logical solution given technical devices and apps already available in management of type 1 diabetes (DMT1). Presently available data are scarce, but encouraging regarding glycemic control in long standing DMT1, new onset DMT1 and minimizing acute complications.
Publish Date	2021-06-04 13:47
Citation	Bilic Curcic I, Cigrovski Berkovic M, Kizivat T, Canecki Varzic S, Smolic R, Smolic M. Effect of COVID-19 on management of diabetes type 1: Pushing the boundaries of telemedical healthcare. World J Diabetes 2021; 12(6): 780-785
URL	https://www.wjgnet.com/1948-9358/full/v12/i6/780.htm
DOI	https://dx.doi.org/10.4239/wjd.v12.i6.780

Full Article (PDF)	WJD-12-780.pdf
Full Article (Word)	WJD-12-780.docx
Manuscript File	62587-Review-FilipodiaCL.docx
Answering Reviewers	62587-Answering reviewers.pdf
Audio Core Tip	62587-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	62587-Conflict-of-interest statement.pdf
Copyright License Agreement	62587-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	62587-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	62587-Language certificate.pdf
Peer-review Report	62587-Peer-review(s).pdf
Scientific Misconduct Check	62587-Scientific misconduct check.pdf
Scientific Editor Work List	62587-Scientific editor work list.pdf